In addition to the classical immune checkpoint molecules PD-1 and CTLA-4, T cell immunoglobulin mucin receptor 3 (TIM3, or HAVCR2) and LAG-3 are also included in the field of tumor immunotherapy research. This evidence concerns the gene CTLA4 and neoplasm.